Prestige Consumer Healthcare Inc. Stock
We can see a decrease in the price for Prestige Consumer Healthcare Inc.. Compared to yesterday it has lost -€1.000 (-1.750%).
Currently there is a rather positive sentiment for Prestige Consumer Healthcare Inc. with 3 Buy predictions and 0 Sell predictions.
With a target price of 64 € there is a slightly positive potential of 14.29% for Prestige Consumer Healthcare Inc. compared to the current price of 56.0 €.
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Cons
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | -1.750% | -2.609% | 1.818% | -28.662% | 4.673% | -0.885% | 48.936% |
| Apollo Medical Holdings, Inc. | -0.940% | 23.256% | 16.484% | -15.200% | 0.000% | -38.817% | - |
| Petmed Express Inc | -3.830% | 1.337% | -4.042% | -39.245% | -18.572% | -85.945% | -91.777% |
| Suzuken Co Ltd | -1.750% | -3.390% | -0.581% | 36.800% | 4.268% | 36.800% | 9.615% |
Comments
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) was upgraded by analysts at Sidoti from a "neutral" rating to a "buy" rating. They now have a $80.00 price target on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare Inc. (NYSE: PBH) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for PBH provided by MarketBeat